Dr.ย Sae-Wonย Han
MD, MS, PhD
Professor of Internal Medicine & Medical Oncologist
corporate_fareSeoul National University Hospital, Seoul
Sae-Won Han
MD, MS, PhD
Prof. Sae-Won Han is a Professor of Internal Medicine and medical oncologist at Seoul National University Hospital (SNUH), where he practises in the Hemato Oncology Department and Medical Oncology Center. His verified clinical specialties are colorectal cancer โ including colon cancer and rectal cancer โ clinical trials, and personalised cancer treatment.
Prof. Han completed his medical education at Seoul National University College of Medicine, followed by a Master's degree and a Doctorate from Seoul National University Graduate School. With research activity spanning more than two decades, his academic profile lists 272 research outputs, an h-index of 56, and more than 11,000 citations on Scopus. His clinical and translational work focuses on systemic therapy planning for colorectal and metastatic colorectal cancer, biomarker-driven treatment decisions, next-generation sequencing, circulating tumour DNA-directed therapy, and molecular markers such as KRAS and microsatellite status. Seoul National University Hospital specifically lists clinical trials and personalised treatment as areas of his practice focus.
CancerFax can coordinate medical-record review and consultation support for international patients seeking an opinion from Prof. Han at Seoul National University Hospital.
Why Consider Prof. Sae-Won Han?
Prof. Han is one of South Korea's leading academic medical oncologists for colorectal cancer, combining a high-volume research profile with verified clinical focus on personalised and trial-based care at one of Asia's most respected cancer centres.
Areas of Specialisation
Colorectal cancer, systemic therapy, biomarker-driven treatment, and clinical trial oncology
Prof. Han's clinical focus is centred on colorectal cancer โ including colon cancer, rectal cancer, and metastatic colorectal disease. His practice integrates systemic therapy planning, molecular profiling, and access to clinical trials, making him relevant for patients with early-stage, advanced, and recurrent colorectal cancers.
Colorectal Cancer โ Systemic & Personalised Therapy
Comprehensive medical oncology care for colon and rectal cancers, including adjuvant and palliative systemic therapy guided by molecular and biomarker findings.
- arrow_rightFOLFOX-based adjuvant chemotherapy for stage III and high-risk stage II colon cancer
- arrow_rightTreatment sequencing informed by microsatellite and methylation status
- arrow_rightKRAS mutation assessment for treatment planning
- arrow_rightSystemic therapy planning for metastatic and advanced colorectal disease
- arrow_rightAnti-EGFR and VEGF-targeted treatment evaluation based on molecular profile
- arrow_rightRegorafenib and later-line therapy options for refractory disease
Precision Oncology & Molecular Profiling
Biomarker and genomics-based approaches for colorectal cancer, including circulating tumour DNA research and next-generation sequencing applications.
- arrow_rightTargeted sequencing of cancer-related genes to guide systemic treatment
- arrow_rightMolecular profiling to inform prognosis and treatment selection
- arrow_rightctDNA-directed adjuvant chemotherapy research (CLAUDIA trial, KCSG CO22-12)
- arrow_rightLiquid biopsy approaches for treatment monitoring and residual disease assessment
Clinical Trials & Personalised Treatment
Seoul National University Hospital lists clinical trials and personalised treatment as verified focus areas for Prof. Han.
- arrow_rightEligibility assessment for colorectal cancer clinical trials
- arrow_rightParticipation in investigator-initiated and cooperative group trials
Procedures & Clinical Approaches
Systemic treatment planning for colorectal cancer across stages
Prof. Han's clinical practice as a medical oncologist at SNUH covers systemic cancer treatment, molecular and biomarker-guided planning, clinical trial evaluation, and multidisciplinary case review for colorectal cancer patients.
Systemic Cancer Treatment
Medical OncologyChemotherapy and systemic therapy planning for colon and rectal cancers at all stages.
Biomarker & Molecular Treatment Planning
Targeted TherapyMolecularly guided treatment decisions based on KRAS, microsatellite status, methylation, and next-generation sequencing results.
Clinical Trial Assessment
DiagnosisEvaluation for clinical trial eligibility, including investigator-initiated and cooperative group studies in colorectal cancer.
Second Opinion & Multidisciplinary Review
Second OpinionExpert second-opinion assessment for complex or advanced colorectal cancer cases, supported by SNUH's multidisciplinary colorectal cancer programme.
Research & Publications
Colorectal cancer, molecular oncology, and precision medicine
Prof. Han has one of the most prolific research profiles in colorectal oncology in Asia. Seoul National University's research portal lists 272 research outputs, an h-index of 56 (Scopus), and more than 11,244 citations. His work spans colorectal carcinoma, metastatic colorectal cancer, molecular markers, biomarker-driven therapy, and immune oncology.
Seoul National University's research portal lists 272 outputs and an h-index of 56 for Prof. Han. A more detailed publication list is available on the SNU research portal and PubMed.
Education & Training
Prof. Han completed his medical training at Seoul National University College of Medicine, followed by graduate research training at Seoul National University Graduate School, where he earned both a Master's degree and a Doctorate.
Clinical Experience
Prof. Sae-Won Han has been an academic medical oncologist at Seoul National University and Seoul National University Hospital for over two decades, building a career at the intersection of clinical colorectal cancer care and translational oncology research.
How CancerFax Helps You Access Dr. Sae-Won Han
CancerFax is a specialist cancer patient-navigation platform. We help international patients prepare structured medical summaries, assess treatment eligibility, and connect directly with Dr. Sae-Won Han's team โ with full coordination from initial inquiry to consultation.
Medical Report Review
Free review of your pathology results, imaging, molecular profiling, and treatment history โ prepared as a structured clinical summary for Dr. Sae-Won Han's team.
Treatment Eligibility Screening
CancerFax screens your case for eligibility for treatments and clinical programmes available through Dr. Sae-Won Han before you travel, so you arrive with a clear pathway.
Case Submission
We coordinate direct case submission to Dr. Sae-Won Han's department, including all documentation required for clinical review and appointment scheduling.
Appointment & Consultation Coordination
CancerFax manages appointment scheduling with Dr. Sae-Won Han's team, confirming availability and aligning timelines with your travel plans.
Travel, Visa & Logistics Support
We prepare visa invitation letters, provide hospital-proximity accommodation guidance, and coordinate airport transfers for international patients.
Follow-Up & Continuity of Care
After your consultation or treatment, CancerFax facilitates communication between Dr. Sae-Won Han's team and your home oncologist for seamless post-treatment follow-up.
Frequently Asked Questions About Prof. Sae-Won Han
Prof. Sae-Won Han specialises in colorectal cancer, including colon cancer, rectal cancer, and metastatic colorectal cancer. Seoul National University Hospital lists colorectal cancer, clinical trials, and personalised treatment as his verified focus areas.
Prof. Han practises at Seoul National University Hospital (SNUH) in Seoul, South Korea. He is affiliated with the Hemato Oncology Department and the Medical Oncology Center at SNUH.
CancerFax can coordinate medical-record review and consultation support for international patients seeking an opinion from Prof. Han at Seoul National University Hospital, subject to hospital availability and case acceptance. SNUH provides international patient contact services for foreign patients during weekday working hours.
Submit your medical reports โ including pathology, imaging, prior treatment history, and molecular test results โ through CancerFax. The CancerFax team will review the documents, prepare the case for submission, and coordinate next steps with the hospital, subject to availability.
A second-opinion request can be submitted through CancerFax with the patient's pathology reports, imaging, treatment history, and relevant test results including molecular findings. The final consultation format and availability depend on Prof. Han's schedule and the policies of Seoul National University Hospital.
Yes. Seoul National University Hospital lists clinical trials as a verified area of Prof. Han's practice. His published research includes the CLAUDIA colon cancer trial (KCSG CO22-12), a circulating tumour DNA-directed adjuvant chemotherapy study. Patients with advanced or refractory colorectal cancer may be assessed for trial eligibility during consultation.
Connect with Sae-Won Han Today
Share your medical reports for a free preliminary review. Our patient coordinators will help you understand your options and arrange a direct consultation.
Medical Disclaimer: Information on this page is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making any medical decisions.